Current Score:
0
Estimates stroke risk in patients with atrial fibrillation. The adjusted stroke rate was the expected stroke rate per 100 person-years derived from the multivariable model assuming that aspirin was not taken.
Range | Description | Category |
---|---|---|
<1 | Low risk of thromboembolic event. 0.3% risk of event per year if no coumadin. | good |
1 | Low-Moderate risk of thromboembolic event. 0.9% risk of event per year if no coumadin. | intermediate |
≥2 | Moderate-High risk of thromboembolic event. ≥2.9% risk of event per year if no coumadin. | bad |
Therapies recommended by the AFib Clinical Guide are as follows:
CHADS2VASC Score | Recommended Therapy |
---|---|
0 | Aspirin (81-325 mg po daily) |
1 | Aspirin (81-325 mg po daily) or warfarin (INR 2-3, target 2.5) |
≥2 | Warfarin (INR 2-3, target 2.5) |